We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 1-10 of 51

Sanofi v. Hospira, merits of a 55.2 proceeding
  • Gowling WLG
  • Canada
  • December 3 2009

The Court refused to grant an Order of Prohibition against Hospira regarding its docetaxel product


Pfizer v. ratiopharm, motion to amended a previous judgment on the merits
  • Gowling WLG
  • Canada
  • December 3 2009

ratiopharm was successful in the proceeding under the NOC Regulations at the trial level, but the decision was overturned on appeal


Bayer Inc. v. Canada (Health), listing decision
  • Gowling WLG
  • Canada
  • December 3 2009

The Court dismissed a judicial review of the Minister’s decision refusing to list a formulation patent on the Patent Register


Pfizer v. ratiopharm, motion to intervene in appeal of infringement proceedings
  • Gowling WLG
  • Canada
  • December 3 2009

The Court of Appeal denied BIOTEC Canada’s and Eli Lilly’s leave to intervene in Pfizer’s appeal of the Court’s decision to invalidate a patent for amlodipine


Pfizer v. ratiopharm Inc.; interlocutory motion on appeal of impeachment decision
  • Gowling WLG
  • Canada
  • December 3 2009

Pfizer filed a motion to amend the contents of its appeal book, its notice of appeal and its memorandum of fact and law on the appeal to deal with the additional grounds


Bayer v. Canada
  • Gowling WLG
  • Canada
  • May 28 2009

The Court of Appeal dismissed Bayer’s appeal, thus affirming the refusal to list the patent on the Patent Register


Bristol-Myers Squibb v. Apotex
  • Gowling WLG
  • Canada
  • April 7 2009

The Court refused to grant prohibition on the basis that Apotex's allegation in respect of invalidity for obviousness was justified


Abbott v. Sandoz
  • Gowling WLG
  • Canada
  • April 7 2009

The Court of Appeal dismissed the innovator's appeal regarding a finding that the allegation of invalidity was justified


Pfizer v. Apotex
  • Gowling WLG
  • Canada
  • April 7 2009

The Court upheld the decision of the Prothonotary refusing further production of ANDS documents


Canada (Attorney General) v. Celgene Corporation, appeal of a PMPRB decision
  • Gowling WLG
  • Canada
  • January 20 2010

The Court of Appeal overturned the decision of the Trial Judge and restored the decision of the PMPRB providing jurisdiction to the PMPRB over medicines imported under the Special Access Program